Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Enhancing clinical trial design of interventions for posttraumatic stress disorder.

Leon AC, Davis LL.

J Trauma Stress. 2009 Dec;22(6):603-11. doi: 10.1002/jts.20466.

2.

Caution regarding the use of pilot studies to guide power calculations for study proposals.

Kraemer HC, Mintz J, Noda A, Tinklenberg J, Yesavage JA.

Arch Gen Psychiatry. 2006 May;63(5):484-9.

PMID:
16651505
3.

Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology.

Leon AC, Mallinckrodt CH, Chuang-Stein C, Archibald DG, Archer GE, Chartier K.

Biol Psychiatry. 2006 Jun 1;59(11):1001-5. Epub 2006 Feb 28. Review.

PMID:
16503329
4.

Chlorpromazine and reserpine in the treatment of psychoses.

KINROSS-WRIGHT V.

Ann N Y Acad Sci. 1955 Apr 15;61(1):174-82. No abstract available.

PMID:
14377285
5.

The control of deviant behavior in chronically disturbed psychotic patients by the oral administration of reserpine.

CAMPDEN-MAIN BC, WEGIELSKI Z.

Ann N Y Acad Sci. 1955 Apr 15;61(1):117-22. No abstract available.

PMID:
14377279
6.

A controlled trial of reserpine in chronic schizophrenia.

GOLLER ES.

J Ment Sci. 1960 Oct;106:1408-12. No abstract available.

PMID:
13706710
7.

Safety evaluation and confidence intervals when the number of observed events is small or zero.

Jovanovic BD, Zalenski RJ.

Ann Emerg Med. 1997 Sep;30(3):301-6.

PMID:
9287891
8.

Scientific and ethical considerations in the use of placebo controls in clinical trials in psychopharmacology.

Klerman GL.

Psychopharmacol Bull. 1986;22(1):25-9. No abstract available.

PMID:
3726071
9.
Items per page

Supplemental Content

Write to the Help Desk